Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantation

Journal of Heart and Lung Transplantation

Volumn 32, Issue 8, 2013, Pages 784-791

  Matsuo, Yoshiki ^a   Cassar, Andrew ^a   Yoshino, Satoshi ^a   Flammer, Andreas J ^a,b   Li, Jing ^a,c   Gulati, Rajiv ^a   Topilsky, Yan ^d   Raichlin, Eugenia ^e   Lennon, Ryan J ^a   Lerman, Lilach O ^a   Rihal, Charanjit S ^a   Kushwaha, Sudhir S ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

calcineurin inhibitors; cardiac allograft vasculopathy; intravascular ultrasound; plaque composition; plaque progression; sirolimus; virtual histology

Indexed keywords

CALCINEURIN INHIBITOR; CALCIUM; RAPAMYCIN;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIAC ALLOGRAFT VASCULOPATHY; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

CALCINEURIN INHIBITORS; CARDIAC ALLOGRAFT VASCULOPATHY; INTRAVASCULAR ULTRASOUND; PLAQUE COMPOSITION; PLAQUE PROGRESSION; SIROLIMUS; VIRTUAL HISTOLOGY;

FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; RETROSPECTIVE STUDIES; SIROLIMUS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; VASCULAR DISEASES;

EID: 84880299676     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2013.05.015     Document Type: Article

References (23)

1. J. Stehlik, L.B. Edwards, and A.Y. Kucheryavaya The registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult heart transplant report-2011 J Heart Lung Transplant 30 2011 1078 1094
2. H.J. Eisen, E.M. Tuzcu, and R. Dorent Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients N Engl J Med 349 2003 847 858 (Pubitemid 37025404)
3. A. Keogh, M. Richardson, and P. Ruygrok Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial Circulation 110 2004 2694 2700 (Pubitemid 39453021)
4. S.S. Kushwaha, Z. Khalpey, and R.P. Frantz Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity J Heart Lung Transplant 24 2005 2129 2136 (Pubitemid 41814736)
5. E. Raichlin, J.H. Bae, and Z. Khalpey Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation Circulation 116 2007 2726 2733 (Pubitemid 350291245)
6. Y. Topilsky, T. Hasin, and E. Raichlin Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation Circulation 125 2012 708 720
7. M.R. Mehra, M.G. Crespo-Leiro, and A. Dipchand International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010 J Heart Lung Transplant 29 2010 717 727
8. H.M. García-García, G.S. Mintz, and A. Lerman Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting EuroIntervention 5 2009 177 189
9. E. Raichlin, J.H. Bae, and S.S. Kushwaha Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression J Am Coll Cardiol 53 2009 1279 1286
10. P.R. Rickenbacher, F.J. Pinto, and A. Chenzbraun Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound J Am Coll Cardiol 25 1995 171 177
11. A. König, E. Kilian, and H.Y. Sohn Assessment and characterization of time-related differences in plaque composition by intravascular ultrasound-derived radiofrequency analysis in heart transplant recipients J Heart Lung Transplant 27 2008 302 309 (Pubitemid 351375110)
12. G. Sarno, A. Lerman, and J.H. Bae Multicenter assessment of coronary allograft vasculopathy by intravascular ultrasound-derived analysis of plaque composition Nat Clin Pract Cardiovasc Med 6 2009 61 69
13. G.J. Murphy, G.R. Bicknell, and M.L. Nicholson Rapamycin inhibits vascular remodeling in an experimental model of allograft vasculopathy and attenuates associated changes in fibrosis-associated gene expression J Heart Lung Transplant 22 2003 533 541 (Pubitemid 36549052)
14. D. Mancini, S. Pinney, and D. Burkhoff Use of rapamycin slows progression of cardiac transplantation vasculopathy Circulation 108 2003 48 53 (Pubitemid 36859019)
15. S. Arora, T. Ueland, and B. Wennerblom Effect of everolimus introduction on cardiac allograft vasculopathy-results of a randomized, multicenter trial Transplantation 92 2011 235 243
16. S. Arora, I. Erikstad, and T. Ueland virtual histology assessment of cardiac allograft vasculopathy following introduction of everolimus-results of a multicenter trial Am J Transplant 12 2012 2700 2709
17. R.C. Hoogeveen, C.M. Ballantyne, and H.J. Pownall Effect of sirolimus on the metabolism of apoB100-containing lipoproteins in renal transplant patients Transplantation 72 2001 1244 1250 (Pubitemid 33026603)
18. J.A. Beckman, J. Ganz, and M.A. Creager Relationship of clinical presentation and calcification of culprit coronary artery stenoses Arterioscler Thromb Vasc Biol 21 2001 1618 1622 (Pubitemid 34215581)
19. F.J. Sales, B.A. Falcão, and J.L. Falcão Evaluation of plaque composition by intravascular ultrasound "virtual histology": the impact of dense calcium on the measurement of necrotic tissue EuroIntervention 6 2010 394 399
20. T. Nozue, S. Yamamoto, and S. Tohyama Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis Am Heart J 163 2012 191 199 e1
21. S.W. Lee, W.K. Hau, and S.L. Kong Virtual histology findings and effects of varying doses of atorvastatin on coronary plaque volume and composition in statin-naive patients: the VENUS study Circ J 76 2012 2662 2672
22. M.R. Mehra, H.O. Ventura, and S.P. Jain Heterogeneity of cardiac allograft vasculopathy: clinical insights from coronary angioscopy J Am Coll Cardiol 29 1997 1339 1344 (Pubitemid 27201955)
23. G.W. Stone, A. Maehara, and A.J. Lansky A prospective natural-history study of coronary atherosclerosis N Engl J Med 364 2011 226 235